Symbols / HELP Stock $5.77 +17.04% Cybin D/B/A Helus Pharma
HELP (Stock) Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 287.89M | Enterprise Value | 758.26M | Income | -123.22M | Sales | — | Book/sh | 0.05 | Cash/sh | 0.00 |
| Dividend Yield | — | Payout | 0.00% | Employees | 50 | IPO | — | P/E | — | Forward P/E | -1.79 |
| PEG | — | P/S | — | P/B | 107.35 | P/C | — | EV/EBITDA | -6.36 | EV/Sales | — |
| Quick Ratio | 12.36 | Current Ratio | 13.78 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -4.30 | EPS next Y | -3.22 |
| EPS Growth | — | Revenue Growth | — | Earnings | 2026-02-13 | ROA | -31.95% | ROE | -55.89% | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 49.89M | Shs Float | 90.79M | Short Float | — |
| Short Ratio | 2.79 | Short Interest | — | 52W High | 9.83 | 52W Low | 4.29 | Beta | 1.04 | Avg Volume | 1.02M |
| Volume | 2.50M | Target Price | $43.97 | Recom | Strong_buy | Prev Close | $4.93 | Price | $5.77 | Change | 17.04% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-25.25
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
No recent news from Yahoo. Try the RSS feed for latest HELP news.
Insider Transactions
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|